Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01730118
Title Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

urinary bladder cancer

colon cancer

prostate cancer

Advanced Solid Tumor

renal cell carcinoma

Her2-receptor positive breast cancer

lung non-small cell carcinoma

ovarian cancer

Therapies

HER2 Vaccine

Age Groups: adult
Covered Countries USA


No variant requirements are available.